Downing Ventures and Gresham House backed the latest funding round to support software kit development.
"As we transition out of numerous lockdowns, businesses globally are realigning their working environments and travel policies to meet this new way of working. Virtual and hybrid meetings now have a permanent place in their communications and marketing channels, and we’re innovating to support that. It’s a very interesting time for us at Glisser as we embark on the next stage of our growth journey."
The seed round was co-led by Cambridge Innovation Capital and Oxford Science Enterprises to accelerate the development of photonic artificial intelligence processors.
"Salience Labs brings together deep domain expertise in photonics, electronics and CMOS manufacture."
The financing round was backed by prominent legal and technology figures including Ralph Baxter.
"the sheer velocity and rate of change facing today’s legal departments has created new challenges requiring new age thinking. LawAdvisor is addressing these challenges with its remarkably innovative tools. Tools that offer organizations the opportunity of achieving operational excellence"
Ahren and Speedinvest co-led the seed round to help the data collaboration platform expand its engineering and design teams.
"Where traditionally the legal process behind sharing raw data between parties can take months or even years, Bitfount’s secure network instead allows algorithms to travel to datasets rather than the other way around, which means there needn’t be any disclosure of sensitive information. This new paradigm unlocks opportunities for both analysis and machine learning that were previously impossible – either because they required sharing of sensitive raw data, or because the contractual agreements were prohibitively complex."
The Cheshire healthcare company has raised a financing facility from Tradeplus24 starting at £1.8m and scaling to £5m.
"We’re delighted to have received the funding approval from Tradeplus24. It’s a significant deal which underpins the wider confidence into the life sciences sector and one which will help us to bolster our presence across the UK."
